Pharmacokinetic and Safety Study of Niraparib With Normal or Moderate Hepatic Impairment Patients

NCT03359850 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

17

Enrollment

INDUSTRY

Sponsor class

Conditions

Ovarian Neoplasms
Neoplasms
Solid Tumor
Hepatic Impairment

Interventions

DRUG: Niraparib

Sponsor

Tesaro, Inc.